Published in Health Econ on January 01, 2000
Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet (2009) 3.04
National mental health programme: Manpower development scheme of eleventh five-year plan. Indian J Psychiatry (2011) 1.48
The Global Burden of Disease assessments--WHO is responsible? PLoS Negl Trop Dis (2007) 1.42
Estimation of impact of surgical disease through economic modeling of cleft lip and palate care. World J Surg (2010) 1.40
Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base. Cost Eff Resour Alloc (2006) 1.25
Valuation of health states in the US study to establish disability weights: lessons from the literature. Int J Methods Psychiatr Res (2010) 1.15
Cross-national agreement on disability weights: the European Disability Weights Project. Popul Health Metr (2003) 1.12
Putting health metrics into practice: using the disability-adjusted life year for strategic decision making. BMC Public Health (2013) 1.10
Comments on the response by Murray and Lopez. Health Econ (2000) 1.07
Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores. Popul Health Metr (2006) 1.06
How to measure the burden of mortality? J Epidemiol Community Health (2002) 0.98
Packaging health services when resources are limited: the example of a cervical cancer screening visit. PLoS Med (2006) 0.92
Burden of disease and priority setting. Health Econ (2000) 0.92
Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices. Qual Life Res (2007) 0.92
Burden of cancer in Serbia. Croat Med J (2006) 0.82
Health, well-being, and measuring the burden of disease. Popul Health Metr (2012) 0.79
Societal costs of air pollution-related health hazards: A review of methods and results. Cost Eff Resour Alloc (2008) 0.79
Burden of common mental disorders in a community health centre sample. Can Fam Physician (2016) 0.77
Life years at risk: a population health measure from a prevention perspective. Int J Environ Res Public Health (2009) 0.75
Disability weights from a household survey in a low socio-economic setting: how does it compare to the global burden of disease 2010 study? Glob Health Action (2016) 0.75
The Burden of Premature Mortality in Turkey in 2001 and 2008. Balkan Med J (2016) 0.75
Requisite models for strategic commissioning: the example of type 1 diabetes. Health Care Manag Sci (2008) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
A framework for assessing the performance of health systems. Bull World Health Organ (2000) 6.91
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
A critical examination of summary measures of population health. Bull World Health Organ (2000) 5.15
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94
Armed conflict as a public health problem. BMJ (2002) 4.42
Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31
On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66
The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46
Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37
The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84
The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49
Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12
Measuring the burden of disease. Lancet (1998) 1.58
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Hypertension in developing countries. World Health Stat Q (1988) 1.45
Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35
Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33
Tobacco or health. World Health Stat Q (1993) 1.32
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19
Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
On the assessment of maternal mortality. World Health Stat Q (1987) 1.04
A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02
Sex differentials in mortality. WHO Chron (1984) 1.02
Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00
Reducing child mortality. Bull World Health Organ (2000) 0.94
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92
Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91
Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89
Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88
Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86
Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85
Smoking and death in Russia. Tob Control (1998) 0.84
Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83
A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83
Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81
The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81
Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80
Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80
100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79
Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79
Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78
Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78
Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77
Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77
Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77
Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76
In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76
Investigating Australia's burden of disease. Med J Aust (2000) 0.75
Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75
[Preventable deaths: general view]. World Health Stat Q (1989) 0.75
The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75
Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75
Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75
Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75
Health projections. Introduction. World Health Stat Q (1984) 0.75
Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75